9th Annual Cancer Institute Symposium: “Advances in Genitourinary Cancer Care: Innovations & Insights

Friday, April 24, 2026, 8:00 AM - 3:00 PM, Scott Auditorium - SAG6, Cleveland, OH


AMA PRA Category 1 Credits™ (6.00 hours), General Attendance (6.00 hours), Non-Physician Attendance (6.00 hours)

Annual Cancer Insititute Symposium with a focus on Genitourinary Oncology. Presenters will discuss various topics around Genitourinary Oncology. Some of the topics include Advances in Radiation Therapy for Prostate Cancer: Modern Strategies & Clinical Impact, Optimizing Systemic Therapy in Advanced Prostate Cancer, Molecular Pathology & Genomics in Prostate Cancer, Prostate Cancer Survivorship: Men’s Health, Quality of Life & Addressing Disparities, Radioligand Therapy (RLT): New Horizons in GU Oncology,Paradigm Shifts in Non–Muscle Invasive Bladder Cancer (NMIBC), Advanced Kidney Cancer: Personalizing Therapy and more.

1. Evaluate contemporary advances in prostate cancer management, including modern radiation techniques, optimization of systemic therapy, molecular pathology and genomics, survivorship considerations, and emerging radioligand therapies, to inform evidence-based clinical decision-making across disease stages.
2. Analyze evolving treatment paradigms in genitourinary malignancies, with a focus on paradigm shifts in non–muscle invasive bladder cancer, the clinical integration of antibody–drug conjugates, and modern management strategies for localized and advanced kidney cancer.
3. Apply personalized, multidisciplinary approaches to GU oncology care by incorporating molecular diagnostics, patient-centered outcomes, health equity considerations, and novel therapeutic modalities to improve treatment selection and patient quality of life.

The MetroHealth System is accredited by the Ohio State Medical Association to provide continuing medical education for physicians.

Cancellation Policy

Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to [email protected].

The MetroHealth System reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
The MetroHealth System is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

The MetroHealth System adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

The MetroHealth System adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including Faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.